Kazia Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZIA and other ETFs, options, and stocks.About KZIA
Kazia Therapeutics Ltd. is a clinical stage oncology company, which engages in the pharmaceutical research and development business. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
CEOJohn E. Friend
CEOJohn E. Friend
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1994
Founded1994
Employees—
Employees—
KZIA Key Statistics
Market cap6.59M
Market cap6.59M
Price-Earnings ratio-0.61
Price-Earnings ratio-0.61
Dividend yield—
Dividend yield—
Average volume223.65K
Average volume223.65K
High today$0.31
High today$0.31
Low today$0.27
Low today$0.27
Open price$0.299
Open price$0.299
Volume393.77K
Volume393.77K
52 Week high$1.39
52 Week high$1.39
52 Week low$0.1866
52 Week low$0.1866
KZIA News
TipRanks 3d
Kazia Therapeutics' EVT801 Phase 1 clinical trial completes Phase 1 objectives - TipRanks.com - TipRanksKazia Therapeutics announced that the Safety Review Team of the EVT801 Phase 1 clinical trial has concluded that the primary and secondary objectives of stage 1...